title: The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients.
abstract: OBJECTIVE
  Interleukin-6 (IL-6) is a key pro-inflammatory and immune-modulatory cytokine of relevance for cardiovascular (CD) diseases. Cardiovascular risk factors that have been reported include oxidative stress markers [nitric oxide (NO), malondialdehyde (MDA), disulphite (SH)]. We aimed to evaluate the relation between the IL-6 G/C gene polymorphism and oxidative stress markers in polycystic ovary syndrome (PCOS) patients.
  
  
  METHODS
  We studied 85 PCOS patients and 115 healthy controls. PCOS was defined by the Rotterdam PCOS consensus criteria.
  
  
  RESULTS
  The genotype IL-6 distribution did differ between the control group (CC 9.6%, GC 63.4%, GG 27.0%) and the PCOS patients (CC 4.7%, GC 29.4%, GG 65.9%) (p<0.001). The frequency of the polymorphic G allele was also not similar for the group with PCOS as for the control group with 80.6% and 58.7%, respectively (p<0.001). No statistically significant difference was determined for MDA and NO levels in PCOS patients and control group (p>0.05). Only SH levels were found to be high in favor of patient group (p<0.05). No statistically significant difference was determined between IL-6 G/C gene polymorphism and oxidative stress markers in PCOS patients and in the control group.
  
  
  CONCLUSIONS
  Gene polymorphism of IL-6 -174 G>C is a risk factor for PCOS in Turkish patients. IL-6 gene polymorphisms are not related to NO, MDA, and SH levels in PCOS. Our negative results in risks factors of CV disorders can probably be explained by the fact that metabolic parameters and endothelial systems of patients may not yet be affected in this short period of time.
authors.affiliation: Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, 35100, Izmir, Turkey. drmerdogan61@yahoo.com
authors.forename: M
authors.initials: M
authors.lastname: Erdogan
authors.forename: M
authors.initials: M
authors.lastname: Karadeniz
authors.forename: A
authors.initials: A
authors.lastname: Berdeli
authors.forename: G
authors.initials: G
authors.lastname: Alper
authors.forename: O
authors.initials: O
authors.lastname: Caglayan
authors.forename: C
authors.initials: C
authors.lastname: Yilmaz
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000378:metabolism*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D009569:Nitric Oxide / Q000097:blood; D018384:Oxidative Stress; D011085:Polycystic Ovary Syndrome / Q000235:genetics / Q000276:immunology; D020641:Polymorphism, Single Nucleotide; D013447:Sulfites / Q000097:blood; D014421:Turkey; D055815:Young Adult
chemical_list: D015415:Biomarkers; D015850:Interleukin-6; D013447:Sulfites; D009569:Nitric Oxide; D008315:Malondialdehyde
references.citation: Diabetologia. 2003 May;46(5):625-33
references.pmid: 12739017
references.citation: J Clin Invest. 1996 Jun 1;97(11):2601-10
references.pmid: 8647954
references.citation: Atherosclerosis. 2000 Sep;152(1):203-8
references.pmid: 10996356
references.citation: Nitric Oxide. 2001 Feb;5(1):62-71
references.pmid: 11178938
references.citation: Anal Biochem. 1968 Oct 24;25(1):192-205
references.pmid: 4973948
references.citation: Clin Hemorheol Microcirc. 2005;33(1):41-6
references.pmid: 16037631
references.citation: Fundam Clin Pharmacol. 2002 Dec;16(6):441-53
references.pmid: 12685502
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: Int J Cardiol. 2005 Sep 1;103(3):266-71
references.pmid: 16098388
references.citation: Circulation. 2002 Oct 22;106(17):2250-6
references.pmid: 12390956
references.citation: Redox Rep. 2005;10(5):265-70
references.pmid: 16354415
references.citation: J Clin Invest. 1995 Jul;96(1):60-8
references.pmid: 7542286
references.citation: Hormones (Athens). 2006 Jul-Sep;5(3):171-8
references.pmid: 16950750
references.citation: Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1920-5
references.pmid: 16741147
references.citation: Hypertension. 1993 Feb;21(2):129-35
references.pmid: 8428775
references.citation: Fertil Steril. 2001 Sep;76(3):511-6
references.pmid: 11532474
references.citation: Exp Physiol. 1997 Mar;82(2):291-5
references.pmid: 9129943
references.citation: J Am Soc Nephrol. 2006 Mar;17(3):863-70
references.pmid: 16467451
references.citation: J Clin Endocrinol Metab. 1985 Nov;61(5):946-51
references.pmid: 4044782
references.citation: Fertil Steril. 2004 Jun;81(6):1638-41
references.pmid: 15193488
references.citation: J Clin Endocrinol Metab. 2001 Oct;86(10):4666-73
references.pmid: 11600523
references.citation: Przegl Lek. 2006;63(4):234-8
references.pmid: 17080748
references.citation: J Endocrinol Invest. 2006 Mar;29(3):270-80
references.pmid: 16682845
references.citation: Adv Exp Med Biol. 1994;366:165-9
references.pmid: 7771250
references.citation: Hypertension. 1994 Jun;23(6 Pt 2):1121-31
references.pmid: 7515853
references.citation: Hum Reprod. 2004 Jan;19(1):41-7
references.pmid: 14688154
references.citation: Am J Nephrol. 2004 Sep-Oct;24(5):537-42
references.pmid: 15523169
references.citation: Circulation. 2001 Mar 13;103(10):1410-5
references.pmid: 11245645
references.citation: Circulation. 2002 Aug 6;106(6):653-8
references.pmid: 12163423
references.citation: J Midwifery Womens Health. 2006 Nov-Dec;51(6):415-22
references.pmid: 17081931
references.citation: Metabolism. 2006 Mar;55(3):345-52
references.pmid: 16483878
references.citation: J Clin Endocrinol Metab. 2000 Mar;85(3):1334-9
references.pmid: 10720087
references.citation: Int J Immunogenet. 2005 Dec;32(6):349-53
references.pmid: 16313298
references.citation: J Biol Chem. 1993 Oct 5;268(28):21120-9
references.pmid: 7691806
references.citation: Int J Cardiol. 2004 Nov;97(2):205-12
references.pmid: 15458685
references.citation: J Clin Endocrinol Metab. 2003 Feb;88(2):673-9
references.pmid: 12574198
references.citation: Transplant Proc. 2005 Nov;37(9):3796-8
references.pmid: 16386542
references.citation: Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):434-9
references.pmid: 12615693
references.citation: Toxicol Appl Pharmacol. 2006 Sep 15;215(3):250-9
references.pmid: 16643973
references.citation: Diabetes. 1995 Sep;44(9):1054-8
references.pmid: 7657028
references.citation: J Clin Endocrinol Metab. 2004 May;89(5):2160-5
references.pmid: 15126536
references.citation: Circulation. 2005 Mar 22;111(11):1448-54
references.pmid: 15781756
references.citation: Hypertension. 1995 Aug;26(2):327-31
references.pmid: 7635543
references.citation: Diabetologia. 2000 May;43(5):550-7
references.pmid: 10855528
references.citation: Clin Biochem. 2007 Feb;40(3-4):181-7
references.pmid: 17070511
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):742-6
references.pmid: 11836314
references.citation: Thromb Haemost. 2006 May;95(5):802-6
references.pmid: 16676071
references.citation: Hum Reprod. 2000 Apr;15(4):785-9
references.pmid: 10739820
references.citation: Gynecol Obstet Invest. 2002;53(3):157-62
references.pmid: 12053100
references.citation: Tohoku J Exp Med. 2003 Nov;201(3):147-55
references.pmid: 14649736
references.citation: Gynecol Endocrinol. 2001 Jun;15(3):198-201
references.pmid: 11447731
references.citation: N Engl J Med. 1993 Dec 30;329(27):2002-12
references.pmid: 7504210
references.citation: J Clin Endocrinol Metab. 2001 Jun;86(6):2453-5
references.pmid: 11397838